# Hacarus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hacarus

- Industry: Software
- Headquarters: Kyoto, Japan
- Website: www.hacarus.com
- Total disclosed funding: $8.9M
- Latest round: Series B (Nov 17, 2020)
- Investors on record: 17

## About

Based in Japan, Hacarus Inc. specializes in AI-driven solutions that leverage sparse modeling and edge AI technology to provide valuable insights from minimal data, enhancing operational efficiency across various industries.Hacarus Inc. is a technology company focused on AI solutions, founded in 2014 and headquartered in Kyoto-shi, Japan. The company has successfully completed 8 funding deals, with the latest being a Series C round on May 10, 2023, raising JPY 200 million from Daikin Industries. Founder Kenshin Fujiwara has a background in AI technologies, having founded Hacarus to address the growing need for efficient data utilization in manufacturing and construction sectors.Hacarus specializes in AI-driven solutions that focus on sparse modeling and edge AI technology, providing significant insights from minimal data. Its core product offerings include the HACARUS Check Series, an AI visual inspection solution designed to detect defects in precision manufacturing, and the HACARUS KY application, which streamlines hazard prediction activities within the construction industry. These applications enhance operational efficiency by automating visual inspections and making safety protocols accessible across various devices. Hacarus serves clients in manufacturing, construction, and infrastructure, with notable customers including DENSO TEN, BMW, and Mitsubishi Electric, operating primarily in Japan, Europe, and North America.Hacarus generates revenue through service subscriptions and direct partnerships with industry players. The firm establishes contractual agreements for its core products, including the HACARUS Check visual inspection system and the HACARUS KY application for hazard prediction. These agreements typically involve a service fee structure that includes initial setup costs followed by recurring maintenance or subscription fees, ensuring ongoing support and updates for the technology.In May 2023, Hacarus Inc. raised JPY 200 million in Series C funding, which will be allocated towards research and development and recruitment efforts. The company plans to develop and launch new products aimed at enhancing its existing technology offerings. Additionally, Hacarus is targeting expansion into new markets in Asia and North America by the end of 2024, with a focus on industries that require advanced safety and operational efficiencies.

## Funding rounds

- Series B, Nov 17, 2020, $4M — Miyako Capital, Chushin Venture Capital, Resona Capital, Ohara Pharmaceutical Co.,Ltd., MTG Ventures, PARKINSON Laboratories Co., Ltd.
- Series B, Apr 24, 2020, $3.2M — Osaka Gas, Kyoto Capital Partners, DS Pharma Animal Health Co., Ltd., Keihin Lease Capital
- Series A, Oct 5, 2018, $0.9M — Innovation Engine, Kaga Electronics Co., Ltd, PALTEK Corporation
- Seed, Jul 14, 2017, $0.4M — Japan Finance Corporation, MIRAIDOOR
- Seed, Oct 11, 2016, $0.5M — Bank of Kyoto, Miyako Capital, Senshu Ikeda Capital, Chushin Venture Capital

## Investors

- Bank of Kyoto — Seed
- Miyako Capital (https://capitalatlas.ai/funds/miyako-capital) — Seed, Series B
- Senshu Ikeda Capital (https://capitalatlas.ai/funds/senshu-ikeda-capital) — Seed
- Chushin Venture Capital (https://capitalatlas.ai/funds/chushin-venture-capital) — Seed, Series B
- Japan Finance Corporation — Seed
- MIRAIDOOR (https://capitalatlas.ai/funds/miraidoor) — Seed
- Innovation Engine (https://capitalatlas.ai/funds/innovation-engine) — Series A
- Kaga Electronics Co., Ltd — Series A
- PALTEK Corporation — Series A
- Osaka Gas — Series B
- Kyoto Capital Partners (https://capitalatlas.ai/funds/kyoto-capital-partners) — Series B
- DS Pharma Animal Health Co., Ltd. — Series B
- Keihin Lease Capital — Series B
- Resona Capital (https://capitalatlas.ai/funds/resona-capital) — Series B
- Ohara Pharmaceutical Co.,Ltd. — Series B
- MTG Ventures (https://capitalatlas.ai/funds/mtg-ventures) — Series B
- PARKINSON Laboratories Co., Ltd. — Series B